Vasodilation

Showing 26 - 34 of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cardiovascular Diseases, Vasodilation Trial in Quebec (Nutrition)

Completed
  • Cardiovascular Diseases
  • Vasodilation
  • Nutrition
  • Quebec, Canada
    Institute of Nutraceuticals and Functional Foods
Sep 21, 2015

Pulmonary Arterial Hypertension, Vasodilation, Vasoconstriction Trial in Edinburgh (Bosentan, Sitaxsentan, Placebo)

Completed
  • Pulmonary Arterial Hypertension
  • +2 more
  • Edinburgh, Scotland, United Kingdom
    Clinical Research Centre, Western General Hospital
Jul 20, 2015

Vasodilation Trial in Rio Grande (exercise training)

Completed
  • Vasodilation
  • exercise training
  • Rio Grande, Rio Grande do Sul, Brazil
    Priscila Aikawa
Oct 16, 2014

Chronic Kidney Insufficiency, Hypertension, Vasodilation Trial in Aarhus N (Beta-blocker, ACE-inhibitor, Calcium Channel

Completed
  • Chronic Kidney Insufficiency
  • +2 more
  • Beta-blocker, ACE-inhibitor
  • Calcium Channel Blockers, ACE-Inhibitor
  • Aarhus N, Denmark
    Department of Renal Medicine, Aarhus University Hospital, Skejby
Feb 26, 2014

Dyslipidemias, Hypertension, Vasodilation Trial in Nijmegen (Salvia miltiorrhiza extract, Placebo)

Unknown status
  • Dyslipidemias
  • +4 more
  • Salvia miltiorrhiza extract
  • Placebo
  • Nijmegen, Netherlands
    Radboud University Nijmegen Medical Centre
May 23, 2012

Heart Disease, Vasodilation Trial in Edinburgh (Angiotensin II, Noradrenaline infusion)

Completed
  • Heart Disease
  • Vasodilation
  • Angiotensin II
  • Noradrenaline infusion
  • Edinburgh, United Kingdom
    Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Lit
Aug 9, 2010

Heart Disease, Vasodilation Trial in Edinburgh (Apelin infusion, Sodium nitroprusside infusion)

Completed
  • Heart Disease
  • Vasodilation
  • Apelin infusion
  • Sodium nitroprusside infusion
  • Edinburgh, United Kingdom
    Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Lit
Aug 9, 2010

Cardiac Output, High, Cardiac Output, Low, Vasodilation Trial in Bern (Vigileo TM / Flotrac TM (Minimally invasive cardiac

Completed
  • Cardiac Output, High
  • +4 more
  • Vigileo TM / Flotrac TM (Minimally invasive cardiac output system consisting of arterial line sensor and cardiac output monitor)
  • +3 more
  • Bern, Switzerland
    Department of Intensive Care Medicine, University Hospital Insel
Apr 27, 2009

Methotrexate, Vasodilation Trial in Nijmegen (Methotrexate 15 mg/week for 12 weeks)

Completed
  • Methotrexate
  • Vasodilation
  • Methotrexate 15 mg/week for 12 weeks
  • Nijmegen, Netherlands
    Radboud University Nijmegen Medical Centre
Feb 13, 2006